The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose-escalation trial of alpha-tocopheryloxyacetic acid and concurrent trastuzumab in patients with treatment refractory HER2+ metastatic breast cancer.
 
William R Gwin
Consulting or Advisory Role - Puma Biotechnology
 
Jennifer Childs
No Relationships to Disclose
 
Doreen Higgins
No Relationships to Disclose
 
Kellie Ann Burton
No Relationships to Disclose
 
Kristin Kuano
No Relationships to Disclose
 
Lauren Corulli
No Relationships to Disclose
 
James Dai
No Relationships to Disclose
 
Emmanuel T Akporiaye
Employment - Veana Therapeutics
Leadership - Veana Therapeutics
Stock and Other Ownership Interests - Veana Therapeutics
 
Mary L. Disis
Stock and Other Ownership Interests - Epithany
Research Funding - Celgene (Inst); EMD Serono (Inst); Epithany (Inst); Janssen (Inst); Pfizer (Inst); Precigen (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - I am an inventor on patents held by the University of Washington
Travel, Accommodations, Expenses - Precigen